131 related articles for article (PubMed ID: 24699427)
1. Direct health care costs of hospital admissions due to adverse events in The Netherlands.
Magdelijns FJ; Stassen PM; Stehouwer CD; Pijpers E
Eur J Public Health; 2014 Dec; 24(6):1028-33. PubMed ID: 24699427
[TBL] [Abstract][Full Text] [Related]
2. Direct medical costs of adverse events in Dutch hospitals.
Hoonhout LH; de Bruijne MC; Wagner C; Zegers M; Waaijman R; Spreeuwenberg P; Asscheman H; van der Wal G; van Tulder MW
BMC Health Serv Res; 2009 Feb; 9():27. PubMed ID: 19203365
[TBL] [Abstract][Full Text] [Related]
3. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study.
Leendertse AJ; Van Den Bemt PM; Poolman JB; Stoker LJ; Egberts AC; Postma MJ
Value Health; 2011 Jan; 14(1):34-40. PubMed ID: 21211484
[TBL] [Abstract][Full Text] [Related]
4. Acute Hospital Admissions Because of Health Care-Related Adverse Events: A Retrospective Study of 5 Specialist Departments.
Magdelijns FJ; Pijpers E; Rouhl RP; Hannemann PF; ten Broeke RH; Dings JT; Stehouwer CD; Stassen PM
J Am Med Dir Assoc; 2015 Dec; 16(12):1055-61. PubMed ID: 26255710
[TBL] [Abstract][Full Text] [Related]
5. Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study.
Zegers M; de Bruijne MC; Wagner C; Hoonhout LH; Waaijman R; Smits M; Hout FA; Zwaan L; Christiaans-Dingelhoff I; Timmermans DR; Groenewegen PP; van der Wal G
Qual Saf Health Care; 2009 Aug; 18(4):297-302. PubMed ID: 19651935
[TBL] [Abstract][Full Text] [Related]
6. Excess length of stay and economic consequences of adverse events in Dutch hospital patients.
Hoogervorst-Schilp J; Langelaan M; Spreeuwenberg P; de Bruijne MC; Wagner C
BMC Health Serv Res; 2015 Dec; 15():531. PubMed ID: 26626729
[TBL] [Abstract][Full Text] [Related]
7. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
[TBL] [Abstract][Full Text] [Related]
8. Health-care-related adverse events leading to admission in older individuals: incidence, predictive factors and consequences.
Magdelijns FJ; van Avesaath RE; Pijpers E; Stehouwer CD; Stassen PM
Eur J Public Health; 2016 Oct; 26(5):743-748. PubMed ID: 27001795
[TBL] [Abstract][Full Text] [Related]
9. Costs of adverse drug events in German hospitals--a microcosting study.
Rottenkolber D; Hasford J; Stausberg J
Value Health; 2012; 15(6):868-75. PubMed ID: 22999137
[TBL] [Abstract][Full Text] [Related]
10. Costs of osteoporosis related fractures in hospital admitted patients, Tigrai, Northern Ethiopia: a retrospective study.
Bayray A; Enquselassie F; Gebreegziabher Z
Ethiop Med J; 2013 Jul; 51(3):177-86. PubMed ID: 24669674
[TBL] [Abstract][Full Text] [Related]
11. Surgical adverse events, risk management, and malpractice outcome: morbidity and mortality review is not enough.
Morris JA; Carrillo Y; Jenkins JM; Smith PW; Bledsoe S; Pichert J; White A
Ann Surg; 2003 Jun; 237(6):844-51; discussion 851-2. PubMed ID: 12796581
[TBL] [Abstract][Full Text] [Related]
12. Costs associated with adverse events among acute patients.
Kjellberg J; Wolf RT; Kruse M; Rasmussen SR; Vestergaard J; Nielsen KJ; Rasmussen K
BMC Health Serv Res; 2017 Sep; 17(1):651. PubMed ID: 28903748
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.
Meier F; Maas R; Sonst A; Patapovas A; Müller F; Plank-Kiegele B; Pfistermeister B; Schöffski O; Bürkle T; Dormann H
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):176-86. PubMed ID: 24934134
[TBL] [Abstract][Full Text] [Related]
14. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands.
Damen NL; Baines R; Wagner C; Langelaan M
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):32-39. PubMed ID: 27193415
[TBL] [Abstract][Full Text] [Related]
15. Changes in adverse event rates in hospitals over time: a longitudinal retrospective patient record review study.
Baines RJ; Langelaan M; de Bruijne MC; Asscheman H; Spreeuwenberg P; van de Steeg L; Siemerink KM; van Rosse F; Broekens M; Wagner C
BMJ Qual Saf; 2013 Apr; 22(4):290-8. PubMed ID: 23293136
[TBL] [Abstract][Full Text] [Related]
16. Public hospital admissions for treating complications of clinical care: incidence, costs and funding strategy.
McNair P; Jackson T; Borovnicar D
Aust N Z J Public Health; 2010 Jun; 34(3):330-3. PubMed ID: 20618279
[TBL] [Abstract][Full Text] [Related]
17. [Direct costs and hospital morbimortality impact from preventable adverse drug events].
Pinzón JF; Maldonado C; Díaz JA; Segura O
Biomedica; 2011; 31(3):307-15. PubMed ID: 22674307
[TBL] [Abstract][Full Text] [Related]
18. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
19. Representative case series from New Zealand public hospital admissions in 1998--III: adverse events and death.
Briant R; Buchanan J; Lay-Yee R; Davis P
N Z Med J; 2006 Mar; 119(1231):U1909. PubMed ID: 16582971
[TBL] [Abstract][Full Text] [Related]
20. Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events.
Aranaz-Andrés JM; Aibar-Remón C; Vitaller-Murillo J; Ruiz-López P; Limón-Ramírez R; Terol-García E;
J Epidemiol Community Health; 2008 Dec; 62(12):1022-9. PubMed ID: 19008366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
